Q2 2012

Source filing unavailable

Q2 2012 · —

Revenue

$6.29M

no prior Q2 2011 on file

Net Income

-$5.51M

no prior Q2 2011 on file

EPS Diluted

-$2.18

no prior Q2 2011 on file

Operating Income-$6,123,000—

Margins · derived

Operating margin-97.4%

Net margin-87.7%

Same quarter

no prior Q2 2011 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Agios Pharmaceuticals, Inc. · CIK 1439222 · Engraved from SEC EDGAR